Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000905718-05-000172
Filing Date
2005-07-19
Accepted
2005-07-19 14:27:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC13DAM5 spectrum13dam5.txt SC 13D/A 16032
  Complete submission text file 0000905718-05-000172.txt   18254
Mailing Address 157 TECHNOLOGY DR IRVINE CA 92618
Business Address 157 TECHNOLOGY DR IRVINE CA 92618 9497886700
SPECTRUM PHARMACEUTICALS INC (Subject) CIK: 0000831547 (see all company filings)

EIN.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49329 | Film No.: 05961357
SIC: 2834 Pharmaceutical Preparations

Mailing Address CARNEGIE HALL TOWER 152 W 57TH ST 21ST FLOOR NEW YORK NY 10019
Business Address CARNEGIE HALL TOWER 152 W 57TH ST 21ST FLOOR NEW YORK NY 10019 2122478200
XMARK ASSET MANAGEMENT LLC (Filed by) CIK: 0001118481 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A